Literature DB >> 32156783

Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinases.

Sarah J Trevelyan1, Jodi L Brewster1, Abigail E Burgess1, Jennifer M Crowther2, Antonia L Cadell3, Benjamin L Parker4, David R Croucher3,5,6, Renwick C J Dobson2,7, James M Murphy8,9, Peter D Mace10.   

Abstract

Apoptosis signal-regulating kinases (ASK1, ASK2, and ASK3) are activators of the p38 and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) pathways. ASK1-3 form oligomeric complexes known as ASK signalosomes that initiate signaling cascades in response to diverse stress stimuli. Here, we demonstrated that oligomerization of ASK proteins is driven by previously uncharacterized sterile-alpha motif (SAM) domains that reside at the carboxy-terminus of each ASK protein. SAM domains from ASK1-3 exhibited distinct behaviors, with the SAM domain of ASK1 forming unstable oligomers, that of ASK2 remaining predominantly monomeric, and that of ASK3 forming a stable oligomer even at a low concentration. In contrast to their behavior in isolation, the ASK1 and ASK2 SAM domains preferentially formed a stable heterocomplex. The crystal structure of the ASK3 SAM domain, small-angle x-ray scattering, and mutagenesis suggested that ASK3 oligomers and ASK1-ASK2 complexes formed discrete, quasi-helical rings through interactions between the mid-loop of one molecule and the end helix of another molecule. Preferential ASK1-ASK2 binding was consistent with mass spectrometry showing that full-length ASK1 formed hetero-oligomeric complexes incorporating large amounts of ASK2. Accordingly, disrupting the association between SAM domains impaired ASK activity in the context of electrophilic stress induced by 4-hydroxy-2-nonenal (HNE). These findings provide a structural template for how ASK proteins assemble foci that drive inflammatory signaling and reinforce the notion that strategies to target ASK proteins should consider the concerted actions of multiple ASK family members.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32156783     DOI: 10.1126/scisignal.aay6318

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  7 in total

1.  Oxidant-Sensitive Inflammatory Pathways and Male Reproductive Functions.

Authors:  Sulagna Dutta; Pallav Sengupta; Srikumar Chakravarthi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  The role and regulation of apoptosis signal-regulated kinase 1 in liver disease.

Authors:  Yining Lu; Yanning Liu; Min Zheng
Journal:  Mol Biol Rep       Date:  2022-08-21       Impact factor: 2.742

3.  Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations.

Authors:  A Maxwell Burroughs; L Aravind
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

Review 4.  The 14-3-3 Proteins as Important Allosteric Regulators of Protein Kinases.

Authors:  Veronika Obsilova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

5.  Granulovirus PK-1 kinase activity relies on a side-to-side dimerization mode centered on the regulatory αC helix.

Authors:  Michael R Oliver; Christopher R Horne; Safal Shrestha; Jeremy R Keown; Lung-Yu Liang; Samuel N Young; Jarrod J Sandow; Andrew I Webb; David C Goldstone; Isabelle S Lucet; Natarajan Kannan; Peter Metcalf; James M Murphy
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

6.  Cells recognize osmotic stress through liquid-liquid phase separation lubricated with poly(ADP-ribose).

Authors:  Kengo Watanabe; Kazuhiro Morishita; Xiangyu Zhou; Shigeru Shiizaki; Yasuo Uchiyama; Masato Koike; Isao Naguro; Hidenori Ichijo
Journal:  Nat Commun       Date:  2021-03-01       Impact factor: 14.919

Review 7.  Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.

Authors:  Veronika Obsilova; Karolina Honzejkova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.